Discovery of New 1,3,4-Oxadiazoles with Dual Activity Targeting the Cholinergic Pathway as Effective Anti-Alzheimer Agents.
Elghazawy NH, Zaafar D, Hassan RR, Mahmoud MY, Bedda L, Bakr AF, Arafa RK.
Elghazawy NH, et al.
ACS Chem Neurosci. 2022 Apr 20;13(8):1187-1205. doi: 10.1021/acschemneuro.1c00766. Epub 2022 Apr 4.
ACS Chem Neurosci. 2022.
PMID: 35377601
Our synthesized compounds displayed excellent in vitro enzyme inhibitory activity at nanomolar (nM) concentrations against two major AD disease-modifying targets, i.e., acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). Among our compounds, 5e was considered th …
Our synthesized compounds displayed excellent in vitro enzyme inhibitory activity at nanomolar (nM) concentrations against two major AD dise …